South America Immunohistochemistry Market Drivers and Forecasts by 2028

The SAM immunohistochemistry market is expected to grow from US$ 129.48 million in 2021 to US$ 202.68 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028.

Brazil and Argentina are major economies in SAM. Development opportunities in emerging countries is expected to fuel the market growth. The emerging markets across the region are creating significant opportunities for the key market players to expand their business. It is likely to be a prime factor contributing to the market growth during the coming years. Majority of the players concentrate on developing markets, owing to the large population suffering from chronic diseases in the region. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in some growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry scope. Advancements in biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of a more significant number of immunoassay systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. Hence, healthcare companies can target patients or consumers in the region. There has been an increase in the healthcare expenditure of the countries during the previous years. Various players in the industry have been investing a significant amount of their revenue in research and development activities for the development of better and advanced products and technologies to be used in the healthcare industry. Presence of significant biopharmaceutical companies in the region and the growing number of local companies are the factors contributing to the market growth in the region. These activities in the region are increasing the demand for immunohistochemistry. Thus, the rising number of infectious disease incidences and advancements in emerging countries are likely to boost the market and are anticipated to provide significant growth opportunities to the players operating in the SAM market during the forecast period.

Countries in SAM, especially Brazil, are highly affected due to the COVID-19 outbreak. The outbreak has stringently affected medical services in the region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, and Colombia are affected by the second wave of the COVID-19 outbreak. According to Worldometer, as of September 3, 2021, Brazil reported 558,597 casualties and 21 million new COVID-19 cases. There were 5.2 million new cases in Argentina, a sign of the second wave of COVID-19 outbreak. It is anticipated that SAM will impose a second lockdown, which will eventually hamper the healthcare industry in the region. Brazil, Argentina, Uruguay, Chile, Peru, and Colombia are concerned by the second wave. Amongst which Brazil has registered the majority of the deaths.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM immunohistochemistry market. The SAM immunohistochemistry market is expected to grow at a good CAGR during the forecast period. 

SAM Immunohistochemistry Market Segmentation         

SAM Immunohistochemistry Market – By Product

• Equipment
  • Slide Staining Systems
  • Tissue Microarray Systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
• Antibodies
  • Primary Antibodies
  • Secondary Antibodies
• Reagents
  • Histological Stains
  • Blocking and Fixation Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Stabilizers
  • Organic Solvents
  • Proteolytic Enzymes
  • Diluents
• Kits

SAM Immunohistochemistry Market – By Application

• Diagnostics
  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Diabetes Mellitus
  • Nephrological Diseases
  • Others
• Drug Testing

SAM Immunohistochemistry Market – By End User

• Hospitals and Diagnostic Laboratories
• Research Institutes
• Others

SAM Immunohistochemistry Market, by Country

• Brazil
• Argentina
• Rest of SAM

SAM Immunohistochemistry Market - Companies Mentioned

• Abcam plc
• Agilent Technologies, Inc.
• Bio SB
• BIO-RAD LABORATORIES INC.
• Danaher
• F. HOFFMANN-LA ROCHE LTD.
• MERCK KGaA 
• PerkinElmer Inc.
• THERMO FISHER SCIENTIFIC INC.   

South America Immunohistochemistry Report Scope